Clinical Trials Directory

Trials / Unknown

UnknownNCT05459610

Automatic Evaluation of the Extent of Intestinal Metaplasia With Artificial Intelligence

Development and Validation of an Artificial Intelligence System for Automatic Evaluation of the Extent of Intestinal Metaplasia

Status
Unknown
Phase
Study type
Observational
Enrollment
600 (estimated)
Sponsor
Shandong University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Gastric intestinal metaplasia(GIM) is an important stage in the gastric cancer(GC). With technical advance of image-enhanced endoscopy (IEE), studies have demonstrated IEE has high accuracy for diagnosis of GIM. The endoscopic grading system (EGGIM), a new endoscopic risk scoring system for GC, have been shown to accurately identify a wide range of patients with GIM. However, the high diagnostic accuracy of GIM using IEE and EGGIM assessments performed all require much experience, which limits the application of EGGIM. The investigators aim to design a computer-aided diagnosis program using deep neural network to automatically evaluate the extent of IM and calculate the EGGIM scores.

Detailed description

Globally, gastric cancer is the fifth most prevalent malignancy and the third leading cause of cancer mortality. Gastric intestinal metaplasia (GIM) is an intermediate precancerous gastric lesion in the gastric cancer cascade. Studies have shown that the 5-year cumulative incidence of gastric cancer in IM patients ranges from 5.3% to 9.8% . With technical advance of image-enhanced endoscopy (IEE), studies have demonstrated IEE has high accuracy for diagnosis of GIM. The endoscopic grading system (EGGIM), a new endoscopic risk scoring system for GC, have been shown to accurately identify a wide range of patients with GIM. However, The high diagnostic accuracy of GIM using IEE and EGGIM assessments performed all require much experience, which limits the application of EGGIM. The investigators aim to design a computer-aided diagnosis program using deep neural network to automatically evaluate the extent of IM and calculate the EGGIM scores.

Conditions

Timeline

Start date
2022-07-01
Primary completion
2023-12-30
Completion
2023-12-30
First posted
2022-07-15
Last updated
2022-07-15

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05459610. Inclusion in this directory is not an endorsement.

Automatic Evaluation of the Extent of Intestinal Metaplasia With Artificial Intelligence (NCT05459610) · Clinical Trials Directory